Radar Therapeutics

The next frontier in medicine

Berkeley, United States · Founded 2024 · $13.4M raised

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$13.4M
Last Round
$13.4M SeedMay 2024
Rounds
1

About

Radar Therapeutics is a Berkeley, California-based clinical-stage biotechnology company pioneering precision-expressed mRNA-based therapeutics. Founded in 2022 by synthetic biology pioneers Jim Collins, Eerik Kaseniit, and Xiaojing Gao, the company develops programmable mRNA medicines that activate only in the right cell type and at the right time, enabling highly specific genetic interventions for neurological diseases and aging-related conditions. The platform, which emerged from stealth in 2024 with $13.4M in seed funding, offers a new treatment modality distinct from conventional RNA interference or traditional mRNA delivery.

Summary

Radar Therapeutics is a Biotech company based in Berkeley, United States, founded in 2024. It has raised $13.4M in total across 1 round, most recently a $13.4M Seed round in May 2024. Investors include NFX, Biovision Ventures and KdT Ventures.

Tech & App Stack

3 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMay 2024
$13.4M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Radar Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/radar-therapeutics"><img src="https://indexed.vc/api/badge/company/radar-therapeutics" alt="Radar Therapeutics on Indexed.vc" width="260" height="76" /></a>